1. Home
  2. NVCR vs LCII Comparison

NVCR vs LCII Comparison

Compare NVCR & LCII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • LCII
  • Stock Information
  • Founded
  • NVCR 2000
  • LCII 1956
  • Country
  • NVCR Jersey
  • LCII United States
  • Employees
  • NVCR N/A
  • LCII N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • LCII Auto Parts:O.E.M.
  • Sector
  • NVCR Health Care
  • LCII Consumer Discretionary
  • Exchange
  • NVCR Nasdaq
  • LCII Nasdaq
  • Market Cap
  • NVCR 3.0B
  • LCII 2.8B
  • IPO Year
  • NVCR 2015
  • LCII N/A
  • Fundamental
  • Price
  • NVCR $30.97
  • LCII $103.66
  • Analyst Decision
  • NVCR Buy
  • LCII Hold
  • Analyst Count
  • NVCR 5
  • LCII 6
  • Target Price
  • NVCR $33.40
  • LCII $112.20
  • AVG Volume (30 Days)
  • NVCR 1.9M
  • LCII 256.5K
  • Earning Date
  • NVCR 10-30-2024
  • LCII 02-11-2025
  • Dividend Yield
  • NVCR N/A
  • LCII 4.16%
  • EPS Growth
  • NVCR N/A
  • LCII 164.26
  • EPS
  • NVCR N/A
  • LCII 5.13
  • Revenue
  • NVCR $577,738,000.00
  • LCII $3,775,614,000.00
  • Revenue This Year
  • NVCR $19.13
  • LCII $1.09
  • Revenue Next Year
  • NVCR $5.38
  • LCII $4.36
  • P/E Ratio
  • NVCR N/A
  • LCII $20.40
  • Revenue Growth
  • NVCR 14.63
  • LCII N/A
  • 52 Week Low
  • NVCR $11.70
  • LCII $96.19
  • 52 Week High
  • NVCR $34.13
  • LCII $131.36
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 60.66
  • LCII 26.06
  • Support Level
  • NVCR $29.85
  • LCII $110.53
  • Resistance Level
  • NVCR $34.13
  • LCII $120.58
  • Average True Range (ATR)
  • NVCR 2.00
  • LCII 3.03
  • MACD
  • NVCR -0.33
  • LCII -1.66
  • Stochastic Oscillator
  • NVCR 44.92
  • LCII 4.36

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About LCII LCI Industries

LCI Industries Inc supplies domestically and internationally components for the original equipment manufacturers of recreational vehicles and adjacent industries including buses; and trailers used to haul boats, livestock, equipment, and other cargo. It has two reportable segments; the original equipment manufacturers segment and the aftermarket segment. The OEM Segment manufactures or distributes components for the OEMs of RVs and adjacent industries, including buses; trailers used to haul boats, livestock, equipment, and other cargo; trucks; pontoon boats; trains; manufactured homes; and modular housing. Its products are sold primarily to major manufacturers of RVs such as Thor Industries, Forest River, Winnebago, and other RV OEMs, and to manufacturers in adjacent industries.

Share on Social Networks: